Eotaxin promotes the migration of pre-osteoclasts, which then differentiate into mature osteoclasts, enhancing bone resorption and potentially serving as a candidate biomarker for postmenopausal osteoporosis (39). The gene discussed is CCL11; the disease is postmenopausal osteoporosis.